MAHWAH, N.J., May 4, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will introduce the new DC-8 ultrasound system at the American College of Obstetricians and Gynecologists (ACOG) annual meeting being held in San Diego, May 5-9, 2012. The new system is designed to maximize user experience for a wide variety of applications.
"The DC-8 system is based on advanced technologies, superior image quality and a special focus on ergonomic design as defined by our users," said Michael Thompson, vice president of Ultrasound Sales, Mindray North America. "These combine to help improve patient management, increase ease-of-use and enhance users' overall level of confidence. It offers excellent value while providing superb image quality."
The DC-8 uses Mindray's Multi-Beam Parallel Imaging Technology, which integrates advanced imaging technologies to produce optimized images with minimal user involvement. When combined with the system's echo-enriched beamformer, the DC-8 produces excellent images. Its ergonomic solutions address every part of the user's body that interacts with the device, improving procedural efficiency and reducing repetitive actions. A new user interface enables logical and efficient workflow while ensuring a more convenient operation.
Other Products Showcased
The DC-8 joins the expanding family of Mindray's ultrasound systems. In addition to the new system, the company will also be showcasing the M7, M5, DP 50, DC7 and DC3 at the ACOG next month. All systems allow for upgrades, which will optimize the return on investment for users.
"Mindray will continue to innovate and upgrade our suite of ultrasound systems to provide unsurpassed economic value to our customers," said Thompson. "The DC-8 is just the latest solution to be introduced. We know how critical it is for our clinicians to have confidence in our state-of-the-art ultrasound technology so that we can achieve our mutual goal of providing excellent patient care."
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com.
SOURCE Mindray Medical International Limited